- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$28.1b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$197.79
7D
0.6%
1Y
31.1%
BioNTech
Market Cap: US$22.8b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$90.00
7D
-0.9%
1Y
-9.3%
Illumina
Market Cap: US$18.5b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$122.95
7D
1.2%
1Y
44.7%
Elanco Animal Health
Market Cap: US$12.5b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.83
7D
5.9%
1Y
129.3%
Sam Chun Dang Pharm
Market Cap: ₩18.2t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩795,000.00
7D
1.0%
1Y
353.2%
Regencell Bioscience Holdings
Market Cap: US$11.4b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$26.38
7D
11.5%
1Y
3,157.9%